(AWD-PE-131) PCIe 3.0 x4轉MiniSAS HD36P U.2 NVMe轉接卡－台灣樂天全站4.8折起

網址:http://easymall.co/r/911f4abadb69fc1afa52d594b6276507

平時我自己上網搜尋資料就還蠻喜歡看 (AWD-PE-131) PCIe 3.0 x4轉MiniSAS HD36P U.2 NVMe轉接卡

的

因為可以一網打盡真的是太方便!!!!!

就算沒買過肯定逛過聽過看過 (AWD-PE-131) PCIe 3.0 x4轉MiniSAS HD36P U.2 NVMe轉接卡

吧!!!

(AWD-PE-131) PCIe 3.0 x4轉MiniSAS HD36P U.2 NVMe轉接卡

功能:

(AWD-PE-131) PCIe 3.0 x4轉MiniSAS HD36P U.2 NVMe轉接卡

描述:

(AWD-PE-131) PCIe 3.0 x4轉MiniSAS HD36P U.2 NVMe轉接卡

標題:

食品營養文獻~英翻中~謝謝

發問:

Food ChemistryVolume 114, Issue 2, 15 May 2009, Pages 516-522Identification of pro-drug type ACE inhibitory peptide sourced from porcine myosin B: Evaluation of its antihypertensive effects in vivo AbstractThis study aimed to identify a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from... 顯示更多 Food Chemistry Volume 114, Issue 2, 15 May 2009, Pages 516-522 Identification of pro-drug type ACE inhibitory peptide sourced from porcine myosin B: Evaluation of its antihypertensive effects in vivo Abstract This study aimed to identify a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from porcine skeletal myosin B. Proteins were hydrolyzed with pepsin and the hydrolysates were then subjected to various types of chromatography to isolate the active peptides. The 50% inhibitory concentrations of Lys–Arg–Val–Ile–Gln–Try (M6 a novel peptide) and Val–Lys–Ala–Gly–Phe (A5, a peptide discovered by Ukeda et al. (1991)) were 6.1 and 20.3 μM, respectively. As a result of a homology search, it was determined that the M6 peptide originated from myosin and peptide A5 was of actin origin. M6 is a novel ACE inhibitory peptide, whose activity was shown to be the strongest amongst the previously published myosin-originated peptides. Kinetic evaluations showed that both peptides are competitive inhibitors of ACE. Based on their activity against ACE, M6 was classified as a pro-drug conformer and A5 was classified as a substrate conformer. When both peptides were administered orally to spontaneously hypertensive rats at doses of 10 mg/kg, temporal hypertension was observed after 6 h. This study suggests that M6 and A5 are peptides that may serve several purposes. Based on their remarkable antihypertensive activity, we suggest that M6 and A5 may have potential applications as functional food, which could be used as nutraceutical compounds.

最佳解答:

食品化學 114卷，第2期， 2009年5月15號，第516到522頁鑑定前體藥物來源來自於豬肌球蛋白B組：評價其體內降壓療效摘要本研究在確定一種新型的血管緊張素轉換酶（ ACE ）可抑制豬骨骼肌肌球蛋白灣蛋白水解與胃蛋白酶和蛋白水解物，然後受到各種色譜來分離出活性肽。50 ％抑制濃度的賴氨酸，精氨酸，纈氨酸，異亮氨酸，谷氨酰胺，嘗試（ M6一種新型肽）和Val -賴氨酸，甘氨酸，丙氨酸為6.1和20.3 μm的分別。由於同源性搜索，確定M6肽來自於肌球蛋白和肽第5條是肌動蛋白。 M6是一種新型的血管緊張素轉換酶抑制肽，其活性表明，其中最強烈以前出版肌球蛋白起源肽。動力學評價表明，多肽具有競爭力的血管緊張素轉換酶抑製劑。根據他們對ACE的活性， M6被列為前體藥物構和A5被列為基構。當這兩個多肽口服，以自發性高血壓大鼠在劑量為10毫克/公斤，高血壓，觀察時間後6小時這項研究表明， M6和A5的多肽，可能服務多種用途。基於其出色的抗高血壓活性，我們建議M6和A5可能有潛在的應用，功能性食品，可作為保健品的化合物。有些不太順~但這應該是你要上台報告的題目吧! 我比較建議你看過伊次後,再台上用你的話去講吧！

其他解答:

如果妳要尋找食品類的香精香料，防腐劑，保健食品原料，營業添加劑原料，食用色素,食品添加劑，水果香料,水果香精,商品售價80元起！網址：http://www.cob.tw|||||食品化学容量114，問題2， 2009年5月15日，呼叫516-522 前體藥物類型一點禁止肽的證明來源從豬的肌球蛋白B ：它的抗高血壓藥的評估影響得體內摘要打算的這項研究辨認從豬的骨骼肌球蛋白B.蛋白質的新穎的血管緊縮素我轉換的酵素(一點)禁止肽水解了與蛋白酵素，并且水解物然後被服從對色譜法的各種各樣的类型隔绝活躍肽。 50%禁止集中Lys Arg Val Ile Gln嘗試(M6新穎的肽)和Val Lys丙氨酸Gly Phe (A5， Ukeda等發現的肽(1991)) 分别为6.1和20.3 μM。由於同源查尋，確定M6肽起源于肌球蛋白，并且肽A5是肌動蛋白起源。 M6是新穎的一點禁止肽，活動证明是最強的在以前出版肌球蛋白發源的肽之中。運動評估表示，兩肽是一點競爭抗化劑。为前體藥物conformer和A5分类为基體conformer，基于他們的活動反對一點， M6分类。當兩肽口頭被執行了對本能地在10 mg/kg藥量的高血壓鼠，世俗高血壓在6 h.以後被觀察了。這項研究建議M6和A5是也许符合幾個目的肽。凭他們卓越的抗高血壓藥活動，我們建议M6和A5也许有潛在的應用作為功能食物，可能用作為nutraceutical化合物。希望答案會滿意.

(AWD-PE-131) PCIe 3.0 x4轉MiniSAS HD36P U.2 NVMe轉接卡

94E53E2597D97E71